Rallybio Corporaton

The momentum for this stock is not very good. Rallybio Corporaton is not a good value stock. Rallybio Corporaton is not very popular among insiders. Tradey thinks it is not wise to invest in Rallybio Corporaton.

News

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit

Business Wire Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, announced today...\n more…

Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree

HC Wainwright Reiterates "Buy" Rating for Rallybio (NASDAQ:RLYB)

Zolmax HC Wainwright reaffirmed their buy rating on shares of Rallybio (NASDAQ:RLYB - Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $6.00...\n more…

Rallybio (NASDAQ:RLYB) Given "Buy" Rating at HC Wainwright

Ticker Report HC Wainwright reissued their buy rating on shares of Rallybio (NASDAQ:RLYB - Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a $6.00...\n more…

Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis

We Think Rallybio (NASDAQ:RLYB) Needs To Drive Business Growth Carefully

Simply Wall St There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...\n more…